Cargando…
MicroRNA-331 inhibits development of gastric cancer through targeting musashi1
BACKGROUND: The molecular mechanisms involved in microRNAs (miRNAs) have been extensively investigated in gastric cancer (GC). However, how miR-331 regulates GC pathogenesis remains unknown. AIM: To illuminate the effect of miR-331 on cell metastasis and tumor growth in GC. METHODS: The qRT-PCR, CCK...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755110/ https://www.ncbi.nlm.nih.gov/pubmed/31558975 http://dx.doi.org/10.4251/wjgo.v11.i9.705 |
Sumario: | BACKGROUND: The molecular mechanisms involved in microRNAs (miRNAs) have been extensively investigated in gastric cancer (GC). However, how miR-331 regulates GC pathogenesis remains unknown. AIM: To illuminate the effect of miR-331 on cell metastasis and tumor growth in GC. METHODS: The qRT-PCR, CCK8, Transwell, cell adhesion, Western blot, luciferase reporter and xenograft tumor formation assays were applied to explore the regulatory mechanism of miR-331 in GC. RESULTS: Downregulation of miR-331 associated with poor prognosis was detected in GC. Functionally, miR-331 suppressed cell proliferation, metastasis and tumor growth in GC. Further, miR-331 was verified to directly target musashi1 (MSI1). In addition, miR-331 inversely regulated MSI1 expression in GC tissues. Furthermore, upregulation of MSI1 weakened the inhibitory effect of miR-331 in GC. CONCLUSION: miR-331 inhibited development of GC through targeting MSI1, which may be used as an indicator for the prediction and prognosis of GC. |
---|